Jacob Van Naarden Eli Lilly & CO (LLY) insider trading activity

LLY Quotes by TradingView

Jacob Van Naarden is EVP & Pres., Lilly Oncology of ELI LILLY & Co. Currently has a direct ownership of 19,561 shares of LLY, which is worth approximately $16.4 Million. The most recent transaction as insider was on Feb 10, 2025, when has been sold 6,103 shares (Common Stock) at a price of $868.88 per share, resulting in proceeds of $5,302,774. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 19.6K
65.14% 3M change
21.14% 12M change
Total Value Held $16.4 Million

Jacob Van Naarden Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 10 2025
BUY
Grant, award, or other acquisition
$5,302,774 $868.88 p/Share
6,103 Added 23.78%
19,561 Common Stock
Feb 01 2025
SELL
Payment of exercise price or tax liability
$1,142,811 $811.08 p/Share
1,409 Reduced 9.48%
13,458 Common Stock
Feb 01 2025
BUY
Exercise of conversion of derivative security
-
3,023 Added 16.9%
14,868 Common Stock
Oct 31 2024
SELL
Bona fide gift
-
4,302 Reduced 26.64%
11,845 Common Stock
Feb 12 2024
BUY
Grant, award, or other acquisition
$1,746,568 $737.26 p/Share
2,369 Added 12.79%
16,147 Common Stock
Feb 01 2024
SELL
Payment of exercise price or tax liability
$1,087,852 $645.61 p/Share
1,685 Reduced 10.9%
13,778 Common Stock
Feb 01 2024
BUY
Exercise of conversion of derivative security
-
3,618 Added 18.96%
15,463 Common Stock
Feb 16 2023
SELL
Payment of exercise price or tax liability
$440,203 $335.01 p/Share
1,314 Reduced 9.99%
11,845 Common Stock
Feb 16 2023
BUY
Exercise of conversion of derivative security
-
2,785 Added 17.47%
13,159 Common Stock
Feb 10 2023
BUY
Grant, award, or other acquisition
$830,703 $345.12 p/Share
2,407 Added 18.83%
10,374 Common Stock
Feb 16 2022
SELL
Payment of exercise price or tax liability
$533,034 $243.84 p/Share
2,186 Reduced 21.53%
7,967 Common Stock
Feb 16 2022
BUY
Exercise of conversion of derivative security
-
5,461 Added 34.98%
10,153 Common Stock
JVN

Jacob Van Naarden

EVP & Pres., Lilly Oncology
Indianapolis, IN

Track Institutional and Insider Activities on LLY

Follow ELI LILLY & Co and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LLY shares.

Notify only if

Insider Trading

Get notified when an Eli Lilly & CO insider buys or sells LLY shares.

Notify only if

News

Receive news related to ELI LILLY & Co

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on LLY